A stratified model for health outcomes in ankylosing spondylitis
- 1 October 2011
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 70 (10) , 1758-1764
Abstract
Objective To investigate the relationships between several health outcomes in ankylosing spondylitis (AS). Methods Baseline pretreatment data from 214 patients with AS participating in the AS Study for the Evaluation of Recombinant Infliximab Therapy were analysed. Measures of health-related quality of life (HRQoL) and physical function were used as dependent variables in linear regression analysis. Associations between HRQoL (36-Item Short Form (SF-36)), physical function, clinical disease activity, spinal mobility, structural damage, MRI inflammation, disease duration, age, gender, body mass index and HLA-B27 were explored. Univariate associations were retested in multivariate models. The robustness of the models was evaluated by sensitivity analyses. Results The physical component of SF-36 was independently associated with measures of physical function and disease activity (adjusted R2 (adjR2)=0.39–0.40). The mental component of SF-36 was independently associated with physical function (adjR2=0.07). Physical function was independently associated with measures of spinal mobility and disease activity (adjR2=0.39–0.45). Spinal mobility was hierarchically shown to be an intermediate variable between structural damage and physical function, while physical function was shown to be intermediate between spinal mobility and the physical component of SF-36. Conclusion According to the proposed stratified model for health outcomes in AS, HRQoL is determined by physical function and disease activity, physical function is determined by spinal mobility and disease activity, and spinal mobility is determined by structural damage and inflammation of the spine. As more is learnt about how to measure AS, knowledge about the disease improves and better decisions can be made on the assessment and treatment of this disease.Keywords
This publication has 23 references indexed in Scilit:
- Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitisAnnals of the Rheumatic Diseases, 2010
- The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritisAnnals of the Rheumatic Diseases, 2009
- Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitisAnnals of the Rheumatic Diseases, 2009
- Outcomes in ankylosing spondylitis: what makes the assessment of treatment effects in ankylosing spondylitis different?Annals of the Rheumatic Diseases, 2006
- Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: A randomized clinical trialArthritis & Rheumatism, 2005
- The Equivalence of SF-36 Summary Health Scores Estimated Using Standard and Country-Specific Algorithms in 10 CountriesJournal of Clinical Epidemiology, 1998
- CONCEPTUALIZING AND DEFINING OUTCOMERheumatology, 1995
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Evaluation of Diagnostic Criteria for Ankylosing SpondylitisArthritis & Rheumatism, 1984
- Toward an Understanding of Patient Outcome MeasurementArthritis & Rheumatism, 1983